P268 Impact of the 2020 COVID-19 lockdown in Switzerland on physical activity in patients with early breast cancer under aromatase-inhibitor therapy. A subanalysis of the SAKK 95/17 WISE trial
Main Authors: | N. Hoefnagels, A. Gautier, A. Müller, S. Schär, L. Rosset, N. Corke Mahbiz, M. Schwitter, U. Güth, A. Jakob, C. Balmelli-Cattelan, C. Leo, M. Fehr, D.R. Thorn, S. Riniker, A. Chouiter-Djebaili, J. Musilova, F. Honecker |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-03-01
|
Series: | Breast |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0960977623003867 |
Similar Items
-
SAKK 21/12: a phase II trial of transdermal CR1447 in breast cancer patients
by: Marcus Vetter, et al.
Published: (2023-01-01) -
Completion and publication of clinical trials in a cooperative group: a cohort study of trials of the Swiss Group for Clinical Cancer Research (SAKK)
by: Benjamin Kasenda, et al.
Published: (2023-04-01) -
Subanalysis of the AUGUSTUS trial
by: T. V. Pavlova, et al.
Published: (2020-09-01) -
The effect of third-generation aromatase inhibitors on aromatase avtivity in visceral adipose tissue
by: D. V. Lytkin, et al.
Published: (2018-08-01) -
Ebüssuûd Efendi ve Şânizâde’nin Sakk Kayıtları Işığında İslam ve Osmanlı Hukukunda İcâre (Kira)
by: İbrahim Ülker
Published: (2023-12-01)